一、中文部分
1. 中央健康保險局（民 91），「全民健康保險與各國健康照護服務系統現況比 較」，網站公布資料。
2. 行政院衛生署（1998），全民健康保險實施二年評估報告。
3. 李竹芬（1994），「我國全民健康保險部分負擔之財務效果推估」，國立政治大 學保險研究所碩士論文。
4. 吳偉仲（1999），「全民健康保險自行負擔實施影響之研究—保險對象類別之 探討」，國立中正大學社會福利研究所碩士論文。
5. 邱永仁（1999），「門診藥費部份負擔制度之探討」，台灣醫界，42（6），頁 45-46。
6. 紀駿輝（1997），「健康保險之部分負擔制度理論基礎之探討」，公共衛生第 23 卷第四期。
7. 洪嘉聲（1997），「存款保險之逆向選擇與道德危機」，國立中正大學國際經濟 研究所碩士論文。
8. 陳孝平、鄭文輝、林芸芸（1997），「從財務制度評估全民健康保險的各種改 革方案」，衛生署八十六年度委託研究計畫。
9. 陳孝平、周麗芳、紀駿輝（1999），「影響全民健康保險醫療費用因素之探討(供 給面)」，中央健康保險局八十七年度委託研究計畫。
10.陳欽賢、劉彩卿、周添城（1998），「自負額制度之探討」，經濟研究（Taipei Economic Inquiry），35:1，頁 83-117。中興經濟學系出版。
11.陳淑貞（1998），影響全民健康保險醫療費用支出分配可能因素之探討，國立 中興大學財政學研究所碩士論文。
12.陳聽安、徐偉初、周麗芳（1998），「國全民健康保險醫療費用部分負擔經濟 效果分析與制度改進之研究」，行政院衛生署全民健康保險監理委員會八十六 年度委託研究計畫。
13.鄭文輝、葉秀珍、蘇建榮（1998），「全民健保保險對象家庭財務負擔與醫療 使用之探討」，中央健保局八十七年度委託研究計畫。
二、外文部分（以英文字第一字母順序排列）
Andersen A.S. and Lakk P.,(1987),＂A model for Physician Utilirion within 2 weeks : Analysis of Norwegian Data, Medical Care＂,26,982-991.
Beck, R.W. & Rosko, M.D., (1987), “The Demand for Health Insurance and Health Care : A Review of the Empirical Literature, Medical Care Review＂, 45(2),291-338.
Brian L. Harris, MPH, Andy Stergachis, PHD, and L. Douglas Ried, PHD,(1990), “The effect of drug co-payments on utilization and cost of pharmaceuticals in a Health Maintenance Organization＂, Medical Care, 28(10), 907-917.
Dean G. Smith,(1993), “The Effects of Copayments and Generic Substitution on the us and costs of prescription drugs＂, Inquiry Vol.30, 189-198.
Donaldson, Can and Gerard, Karen, (1993), “Market Failure in Health Care, Economics of Health Care Financing : theVisible Hand.＂
Earl P. Steinberg, Benjamin Gutierrez, Aiman Momani, Joseph A. Boscarino, Patricia Neuman, and Patricia Deverka, (2000), “ Beyond Survey Data: A Claims-Based Analysis Of Drug Use And Spending By The Elderly＂, Health Affairs, 19(2), 198-209.
Feldstein, M.S.,(1973),＂The Welfare Loss of Excess Health Insurance＂,Journal of Political Economy,81,251-80.
Forman, B., R. B. Valdez, et al. (1987),“The Effect of Cost Sharing on the Use of Antibiotics in Ambulatory Care: Results From a Population-Based Randomized Controlled Trial＂, Journal of Chronic Disease, 40:5, 429-437.
Keeler, E. M. and J. E. Rolph (1988) ,“How cost sharing reduced medical spending of participants in the Health Insurance Experiment＂, Journal of the American Medical Association (JAMA) ,249:16 ,337-367.
Lohr , K. N., R. H. Brook and W. M. Dickson (1984) , “The Effect of
Medicaid Drug Copayment Program on the Utilization and Cost of Prescription Service＂, Medical Care ,22:8 ,724-736
Manning, W. G., Newhouse, J.P., et al., (1987), ＂Health Insurance and the Demand for Medical Care Evidence from a Randomized Experiment＂, American Economic Review, 77(3), pp.251-277.
Manning, W.G. ,Newhouse, J.P. , et al., (1988), “Health Insurance and the Demand for Medical Care : Evidence from a Randomized Experiment, American Economic Review＂, 77(3), 251-277.
Pauly, M.V., (1968), “The Econmics of Moral Hazard : Comment, American Economic Review＂,58, 531-7.
Richard E. Johnson, Michael J. Goodman, Mark C. Hornbrook, and Michael B. Eldredge, (1997), ＂The impact of increasing patient prescription drug cost sharing on therapeutic classed of drugs received and on the health status of elderly HMO members＂, HSR：Health Services Research 32：1, pp.103-122.
Richard E. Johnson, Michael J. Goodman, Mark C. Hornbrook, and Michael B. Eldredge, MS, RPH, (1997), ＂The effect of increased prescription drug cost-sharing on medical care utilization and expenses of elderly Health Maintenance Organization members＂, Medical Care, Vol.35, Number 11, pp.1119-1131.
Smith DG., (1993), “The effects of Copayment and generic substitution on the use and cost of prescription drugs.＂,The Journal of Inquiry, 30(2):189-98.